Boston Scientific (BSX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Boston Scientific (BSX) is Neutral.

The composite score behind that read is -0.15, weighing +0.11 of bullish evidence against -0.46 bearish.

Boston Scientific last closed at $42.73, +1.64% on the session.

Against the IVW growth benchmark the position is +0.84% over the forecast window.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 80%.

20 graded predictions for BSX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Boston Scientific in the 56th percentile on valuation and the 72nd percentile on return on equity, where 100 is best.

Boston Scientific is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $60.93B.

StockMap tracks Boston Scientific as the 5th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite Boston Scientific ranks 107th of 140 in the group, against a group median of -0.03.